{
 "@context": "https://clearank.com/llms.txt",
 "@type": "clearank:AssetAnalysis",
 "url": "https://clearank.com/stock/intuitive-surgical-isrg/",
 "dataUrl": "https://clearank.com/stock/intuitive-surgical-isrg/data.json",
 "title": "Intuitive Surgical (ISRG) Stock Forecast (2026)",
 "description": "Intuitive Surgical Inc. (ISRG) stock: Healthcare, Medical Instruments & Supplies. $126.6B market cap. AI rating, technicals, 2030 forecast and trade plans.",
 "headline": "Intuitive Surgical Inc. (ISRG)",
 "published": "2026-06-26T09:31:16+00:00",
 "modified": "2026-09-10T12:21:59.399+00:00",
 "generated": "2026-09-11T21:51:36.638Z",
 "language": "en-US",
 "publisher": {
  "name": "CleaRank",
  "url": "https://clearank.com/"
 },
 "disclaimer": "Educational and informational only; not financial advice. AI-generated analysis reviewed by the CleaRank editorial team; prices delayed up to 15 minutes.",
 "asset": {
  "ticker": "ISRG",
  "name": "Intuitive Surgical Inc.",
  "type": "Common Stock",
  "exchange": "NASDAQ",
  "currency": "USD",
  "sector": "Healthcare",
  "industry": "Medical Instruments & Supplies",
  "country": "United States",
  "website": "https://www.intuitive.com"
 },
 "quote": {
  "price": 358.08,
  "previousClose": 353.24,
  "change": 4.84,
  "changePercent": 1.37,
  "open": 348.235,
  "high": 358.82,
  "low": 345.35,
  "volume": 11304,
  "averageVolume": 1886830,
  "marketCap": 126558130560,
  "fiftyTwoWeekHigh": 603.88,
  "fiftyTwoWeekLow": 328.57001,
  "marketOpen": false,
  "asOf": "2026-09-10T12:21:58.000Z"
 },
 "statistics": {
  "pe": 40.02635,
  "eps": 8.73,
  "dividendYield": 0,
  "beta": 1.465,
  "priceToSales": 11.34571,
  "priceToBook": 6.806459,
  "revenueTtm": 11034399744,
  "grossMargin": 0.6777996749991356,
  "returnOnEquity": 0.17423001
 },
 "technicals": {
  "rsi": 23.57,
  "macd": -6.01,
  "sma50": 378.87,
  "sma200": 461.77,
  "rsiSignal": "Oversold",
  "trend": "Bearish",
  "pricePosition": "Bearish",
  "macdSignal": "Bearish",
  "rating": "Bearish"
 },
 "analysis": {
  "rating": "Buy",
  "score": 73,
  "consensus": "Buy",
  "fairValue": 484,
  "analystTarget": 484,
  "analystCount": 33,
  "wallStreetConsensus": "Buy",
  "generatedAt": "2026-09-10T12:21:58.000Z",
  "priceAtAnalysis": 358.08,
  "volatility": {
   "daily": 2.22,
   "risk": "standard"
  }
 },
 "tradePlan": {
  "bias": "Bullish",
  "conservativeEntry": 350.92,
  "aggressiveEntry": 358.08,
  "stopLoss": 328.32,
  "stopLossPercent": 6.44,
  "targets": [
   368.46,
   386.01,
   403.56
  ]
 },
 "projections": {
  "basis": "Monte Carlo simulation on historical return distribution, re-run daily; not price targets",
  "years": [
   {
    "year": 2027,
    "downside10th": 261.25,
    "base": 399.51,
    "upside90th": 610.95
   },
   {
    "year": 2028,
    "downside10th": 244.45,
    "base": 445.74,
    "upside90th": 812.76
   },
   {
    "year": 2029,
    "downside10th": 238.29,
    "base": 497.31,
    "upside90th": 1037.88
   },
   {
    "year": 2030,
    "downside10th": 237.26,
    "base": 554.85,
    "upside90th": 1297.55
   },
   {
    "year": 2031,
    "downside10th": 239.46,
    "base": 619.05,
    "upside90th": 1600.38
   },
   {
    "year": 2032,
    "downside10th": 244.01,
    "base": 690.68,
    "upside90th": 1954.98
   },
   {
    "year": 2033,
    "downside10th": 250.47,
    "base": 770.59,
    "upside90th": 2370.81
   },
   {
    "year": 2034,
    "downside10th": 258.59,
    "base": 859.76,
    "upside90th": 2858.55
   },
   {
    "year": 2035,
    "downside10th": 268.23,
    "base": 959.23,
    "upside90th": 3430.41
   },
   {
    "year": 2036,
    "downside10th": 279.33,
    "base": 1070.22,
    "upside90th": 4100.44
   }
  ]
 },
 "faqCount": 7,
 "sources": [
  "TwelveData",
  "Wall Street consensus"
 ],
 "sections": [
  {
   "id": "price",
   "title": "ISRG Price Analysis"
  },
  {
   "id": "market-metrics",
   "title": "Market Metrics",
   "facts": {
    "Open": "$348.24",
    "Day Range": "$345.35 to $358.82",
    "Prev Close": "$353.24",
    "Volume": "11.3K",
    "52-Week Range": "$328.57 to $603.88",
    "Market Cap": "$126.56B"
   }
  },
  {
   "id": "peer-benchmarking",
   "title": "Peer Benchmarking",
   "text": [
    "Sector Position Analysis Valuation is broadly in line with sector peers (-0.009118% difference), suggesting fair market pricing relative to industry standards."
   ]
  },
  {
   "id": "financials",
   "title": "ISRG Financial Performance",
   "text": [
    "Analysis: In the last 5 quarters, ISRG beat estimates 5 times. However, the stock fell 3 times the next day. This suggests positive news is often \"priced in\" or investors are selling the news."
   ]
  },
  {
   "id": "analysis",
   "title": "ISRG Analysis",
   "text": [
    "Intuitive Surgical Inc. (ISRG) is currently trading below its 50-day and 200-day moving averages ($378.87 and $461.77), signaling a bearish trend. The Relative Strength Index (RSI) is at 23.57, indicating the stock is oversold and may be due for a potential bounce. MACD is also negative, further reinforcing the bearish momentum. Key support levels are not clearly defined due to the current downtrend, but the oversold RSI suggests that significant downside may be limited in the short term. Volume has been above average recently, which could indicate increased investor interest, though the price action remains weak. The current technical setup suggests caution, but the oversold condition presents a potential entry point for long-term investors.",
    "Insiders have sold $139.3 million worth of ISRG stock across 138 transactions, indicating potential concerns about future performance or valuation among management.",
    "The Relative Strength Index (RSI) is at 23.57, indicating the stock is in oversold territory and may be due for a technical bounce or short-term recovery.",
    "The median analyst price target of $484.00 suggests a 37% upside from the current price, with a majority of analysts maintaining Buy or Outperform ratings.",
    "Intuitive Surgical Inc. reported 18.5% year-over-year revenue growth, with projections for 17.00% growth in the current year, demonstrating sustained business expansion.",
    "The base case scenario for Intuitive Surgical Inc. (ISRG) anticipates a recovery towards its median analyst target price of $484.00 within the next 6-12 months, driven by its strong market position and consistent revenue growth. The current oversold RSI suggests potential for a near-term rebound, which could be the catalyst for this recovery. The company's projected revenue growth of 17.00% for the current year and 13.00% for the next year provides a solid foundation for this outlook. Potential upside catalysts include a shift in insider sentiment, a successful integration of new technologies, or stronger-than-expected market adoption of its robotic surgery systems. Conversely, sustained heavy insider selling, increased competition, or regulatory hurdles could pressure the stock lower, potentially testing the downside projection of $234.06 from the Monte Carlo simulation."
   ],
   "lists": {
    "ProTips": [
     "Monitor insider transaction activity closely; a reversal from net selling to net buying could signal renewed management confidence.",
     "The current oversold RSI reading (23.57) suggests a potential short-term buying opportunity, but confirmation from price action and volume is advised.",
     "Given the significant insider selling, consider a more conservative position sizing until a clear bullish trend emerges."
    ]
   },
   "catalysts": [
    {
     "type": "Bearish",
     "title": "Heavy Insider Selling Continues",
     "text": "Insiders have sold $139.3 million worth of ISRG stock across 138 transactions, indicating potential concerns about future performance or valuation among management.",
     "source": "Insider Trading Data"
    },
    {
     "type": "Bullish",
     "title": "Oversold RSI Suggests Potential Reversal",
     "text": "The Relative Strength Index (RSI) is at 23.57, indicating the stock is in oversold territory and may be due for a technical bounce or short-term recovery.",
     "source": "Technical Analysis"
    },
    {
     "type": "Bullish",
     "title": "Strong Analyst Conviction and Upside Potential",
     "text": "The median analyst price target of $484.00 suggests a 37% upside from the current price, with a majority of analysts maintaining Buy or Outperform ratings.",
     "source": "Wall Street Analysts"
    },
    {
     "type": "Bullish",
     "title": "Consistent Revenue Growth",
     "text": "Intuitive Surgical Inc. reported 18.5% year-over-year revenue growth, with projections for 17.00% growth in the current year, demonstrating sustained business expansion.",
     "source": "Company Financials"
    }
   ]
  },
  {
   "id": "key-statistics",
   "title": "Key Statistics",
   "text": [
    "Intuitive Surgical Inc. (ISRG) exhibits a P/E ratio of 40.03, which is in line with its sector average, suggesting fair valuation relative to its peers in the medical instruments and supplies industry. The company's revenue growth has been strong, with an 18.5% year-over-year increase reported, and is projected to grow by 17.00% in the current year. This growth is supported by strong forward revenue estimates, with next year's sales expected to increase by 13.00%. While the valuation appears reasonable within its sector, the significant insider selling, totaling $139.3 million, warrants attention. This activity contrasts with the positive analyst sentiment and forward growth projections. Investors should weigh the company's strong market position and growth trajectory against the insider selling signal when considering an investment.",
    "Intuitive Surgical Inc. (ISRG) recently reported an EPS of $2.80 for its latest quarter, surpassing the analyst estimate of $2.50 by 12%. This follows a pattern of consistent earnings beats, including an 18.48% surprise in the prior quarter. The stock experienced a 14.15% price decline following the most recent earnings report, despite the EPS beat, highlighting potential investor concerns or broader market sentiment impacting the stock.",
    "The most significant risk for Intuitive Surgical Inc. (ISRG) is the heavy insider selling, with $139.3 million in dispositions, which could signal a lack of confidence from management. Additionally, the stock is trading significantly below its key moving averages, indicating a bearish technical trend that could persist. Competitive pressures within the robotic surgery market, though currently managed well, remain a long-term consideration."
   ],
   "tables": [
    {
     "caption": "",
     "columns": [],
     "rows": [
      {
       "label": "Market Cap",
       "cells": [
        "126.56B"
       ]
      },
      {
       "label": "P/E Ratio",
       "cells": [
        "40.03"
       ]
      },
      {
       "label": "EPS (TTM)",
       "cells": [
        "8.73"
       ]
      },
      {
       "label": "Dividend Yield",
       "cells": [
        "0.00%"
       ]
      },
      {
       "label": "52 Week High",
       "cells": [
        "603.88"
       ]
      },
      {
       "label": "52 Week Low",
       "cells": [
        "328.57"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "technical-indicators",
   "title": "Technical Indicators",
   "text": [
    "Technical Rating Bearish RSI Oversold SMA Cross Bearish Price vs SMA Bearish MACD Bearish Moving averages show a lagging Death Cross (50-day: $378.87, 200-day: $461.77), price is trading below the 50-day SMA, RSI at 23.6 suggests oversold conditions; potential bounce setup."
   ],
   "facts": {
    "RSI": "Oversold",
    "SMA Cross": "Bearish",
    "Price vs SMA": "Bearish",
    "MACD": "Bearish"
   },
   "tables": [
    {
     "caption": "",
     "columns": [],
     "rows": [
      {
       "label": "RSI (14)",
       "cells": [
        "23.57"
       ]
      },
      {
       "label": "MACD",
       "cells": [
        "-6.01"
       ]
      },
      {
       "label": "SMA 50",
       "cells": [
        "378.87"
       ]
      },
      {
       "label": "SMA 200",
       "cells": [
        "461.77"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "correlations",
   "title": "Market Correlations",
   "text": [
    "How this stock moves relative to other assets",
    "Based on 1 year of daily price data. Correlations may vary over different time periods."
   ],
   "facts": {
    "Correlation with S&P 500 (SPY)": "+0.53",
    "Correlation with Nasdaq 100 (QQQ)": "+0.47",
    "Correlation with Bitcoin (BTC)": "-0.10",
    "Correlation with Gold (XAU)": "+0.07"
   }
  },
  {
   "id": "trade-plans",
   "title": "ISRG Trade Plans",
   "text": [
    "Specific entry, exit, and risk management levels",
    "Lower risk, wait for pullback",
    "Higher risk, immediate entry",
    "Volatility-Adjusted Stop Loss Calculated based on RSI (23.6) and current market volatility",
    "Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3"
   ],
   "facts": {
    "TARGET 1": "$368.46",
    "TARGET 2": "$386.01",
    "TARGET 3": "$403.56",
    "STOP LOSS": "$328.32"
   }
  },
  {
   "id": "seasonality",
   "title": "Seasonal Patterns",
   "text": [
    "Historical monthly performance trends",
    "Based on 3 years of historical monthly returns"
   ],
   "facts": {
    "Average Jan return": "+0.71%",
    "Average Feb return": "-0.31%",
    "Average Mar return": "-1.19%",
    "Average Apr return": "+2.86%",
    "Average May return": "+2.24%",
    "Average Jun return": "+3.29%",
    "Average Jul return": "+1.74%",
    "Average Aug return": "+2.17%",
    "Average Sep return": "-0.72%",
    "Average Oct return": "+3.86%",
    "Average Nov return": "+4.64%",
    "Average Dec return": "+0.37%"
   }
  },
  {
   "id": "risk",
   "title": "Risk & Volatility",
   "facts": {
    "Daily Volatility": "2.22%"
   },
   "lists": {
    "Risk considerations": [
     "Monitor position sizing based on current volatility levels",
     "Consider stop-loss placement beyond recent price range",
     "Diversification helps mitigate single-stock risk exposure"
    ]
   }
  },
  {
   "id": "growth",
   "title": "Growth of $10,000",
   "text": [
    "A $10,000 investment in ISRG in September 2016 would be worth about $46,520 today, compared with about $35,241 for the same investment in the S&P 500 benchmark."
   ]
  },
  {
   "id": "monte-carlo",
   "title": "Monte Carlo Projection (10yr)",
   "text": [
    "CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in ISRG today could grow to about $29,888 by 2036 in the base case, with a bull case near $114,512 and a bear case around $7,801. Projections are statistical simulations, not guarantees."
   ]
  },
  {
   "id": "price-prediction",
   "title": "ISRG Stock Price Prediction: 2030",
   "text": [
    "CleaRank's simulation projects a price near $555 for ISRG by 2030 in the base case, from $358 today (1.5x over 4 years). The downside path ends near $237. These are outcomes of a Monte Carlo simulation run on ISRG's historical return distribution, not price targets, and they assume no dividends are reinvested.",
    "Method: 10,000 simulated price paths using ISRG's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice."
   ],
   "tables": [
    {
     "caption": "ISRG simulated price paths by year",
     "columns": [
      "Year",
      "Downside (10th pct)",
      "Base case",
      "Upside (90th pct)"
     ],
     "rows": [
      {
       "label": "2027",
       "cells": [
        "$261",
        "$400",
        "$611"
       ]
      },
      {
       "label": "2028",
       "cells": [
        "$244",
        "$446",
        "$813"
       ]
      },
      {
       "label": "2029",
       "cells": [
        "$238",
        "$497",
        "$1,038"
       ]
      },
      {
       "label": "2030",
       "cells": [
        "$237",
        "$555",
        "$1,298"
       ]
      },
      {
       "label": "2031",
       "cells": [
        "$239",
        "$619",
        "$1,600"
       ]
      },
      {
       "label": "2032",
       "cells": [
        "$244",
        "$691",
        "$1,955"
       ]
      },
      {
       "label": "2033",
       "cells": [
        "$250",
        "$771",
        "$2,371"
       ]
      },
      {
       "label": "2034",
       "cells": [
        "$259",
        "$860",
        "$2,859"
       ]
      },
      {
       "label": "2035",
       "cells": [
        "$268",
        "$959",
        "$3,430"
       ]
      },
      {
       "label": "2036",
       "cells": [
        "$279",
        "$1,070",
        "$4,100"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "people-also-watch",
   "title": "People Also Watch",
   "links": [
    {
     "text": "BMY Bristol-Myers Squibb Company NYSE $63.37 -0.5961%",
     "url": "https://clearank.com/stock/bristol-myers-squibb-bmy/"
    },
    {
     "text": "A Agilent Technologies, Inc. NYSE $146.93 +2.66%",
     "url": "https://clearank.com/stock/agilent-technologies-a/"
    },
    {
     "text": "OSCR Oscar Health, Inc. NYSE $31.84 +0.2361%",
     "url": "https://clearank.com/stock/oscr-stock-analysis/"
    },
    {
     "text": "DXCM DexCom Inc. NASDAQ $84.51 +0.7511%",
     "url": "https://clearank.com/stock/dxcm-stock-analysis/"
    },
    {
     "text": "TEM Tempus AI Inc NASDAQ $58.74 -4.14%",
     "url": "https://clearank.com/stock/tempus-ai-tem/"
    },
    {
     "text": "CRNX Crinetics Pharmaceuticals, Inc. NASDAQ $84.95 +0.00%",
     "url": "https://clearank.com/stock/crinetics-pharmaceuticals-crnx/"
    },
    {
     "text": "ABBV AbbVie Inc. NYSE $255.00 +1.63%",
     "url": "https://clearank.com/stock/abbvie-abbv/"
    },
    {
     "text": "MRNA Moderna Inc. NASDAQ $148.15 +8.44%",
     "url": "https://clearank.com/stock/moderna-mrna/"
    }
   ]
  },
  {
   "id": "related-comparisons",
   "title": "Popular Comparisons",
   "links": [
    {
     "text": "UEC vs CCJ Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/uec-vs-ccj/"
    },
    {
     "text": "CMG vs CAVA Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/cmg-vs-cava/"
    },
    {
     "text": "SCHD vs VIG Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/schd-vs-vig/"
    }
   ]
  },
  {
   "id": "insider-trading",
   "title": "ISRG Insider Trading Analysis",
   "facts": {
    "Bought": "None",
    "Sold": "$139.3M",
    "Insiders": "23",
    "Avg Transaction": "$2.4M"
   },
   "tables": [
    {
     "caption": "Recent insider transactions in ISRG",
     "columns": [
      "Date",
      "Insider",
      "Type",
      "Shares",
      "Value"
     ],
     "rows": [
      {
       "label": "Feb 28, 2024",
       "cells": [
        "MOHR MARSHALL L Officer",
        "Sell",
        "108.8K",
        "$41.9M"
       ]
      },
      {
       "label": "Feb 7, 2024",
       "cells": [
        "ROSA DAVID J President",
        "Sell",
        "80.7K",
        "$31.4M"
       ]
      },
      {
       "label": "Apr 24, 2023",
       "cells": [
        "ROSA DAVID J Officer",
        "Sell",
        "81.6K",
        "$24.4M"
       ]
      },
      {
       "label": "Aug 23, 2024",
       "cells": [
        "CHARLTON HENRY L Officer",
        "Sell",
        "40.2K",
        "$19.6M"
       ]
      },
      {
       "label": "Apr 26, 2021",
       "cells": [
        "MOHR MARSHALL L Chief Financial Officer",
        "Sell",
        "22.0K",
        "$19.0M"
       ]
      },
      {
       "label": "Jul 31, 2023",
       "cells": [
        "GUTHART GARY S Chief Executive Officer",
        "Sell",
        "55.3K",
        "$18.1M"
       ]
      },
      {
       "label": "Oct 24, 2025",
       "cells": [
        "GUTHART GARY S Officer and Director",
        "Sell",
        "31.6K",
        "$17.3M"
       ]
      },
      {
       "label": "Jul 26, 2022",
       "cells": [
        "GUTHART GARY S Chief Executive Officer",
        "Sell",
        "79.4K",
        "$17.2M"
       ]
      },
      {
       "label": "Feb 14, 2020",
       "cells": [
        "SMITH LONNIE M Director",
        "Sell",
        "28.2K",
        "$16.9M"
       ]
      },
      {
       "label": "Aug 6, 2021",
       "cells": [
        "ROSA DAVID J Officer",
        "Sell",
        "16.2K",
        "$16.4M"
       ]
      }
     ]
    }
   ],
   "links": [
    {
     "text": "SEC Form 4",
     "url": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&company=Intuitive+Surgical+Inc.&type=4&dateb=&owner=include&count=40&search_text=&action=getcompany"
    }
   ]
  },
  {
   "id": "faq",
   "title": "Frequently Asked Questions"
  }
 ],
 "faq": [
  {
   "question": "Is Intuitive Surgical Inc. (ISRG) stock a buy right now?",
   "answer": "Intuitive Surgical Inc. (ISRG) is currently rated as a Buy by Wall Street analysts, with a median price target of $484.00, suggesting a 37% upside from its current price of $353.24. The stock's RSI is oversold, which could indicate a potential near-term bounce, but significant insider selling presents a notable risk."
  },
  {
   "question": "What is ISRG's stock price forecast for 2030?",
   "answer": "Based on Monte Carlo simulations, Intuitive Surgical Inc. (ISRG) has a projected base case price of $547.35 by 2030, with a downside projection of $234.06 and an upside projection of $1280.01. These are statistical outcomes, not guarantees."
  },
  {
   "question": "What are the biggest risks facing Intuitive Surgical Inc. (ISRG)?",
   "answer": "The primary risks for ISRG include significant insider selling totaling $139.3 million, a bearish technical trend with the stock trading below key moving averages, and potential competitive pressures in the robotic surgery market."
  },
  {
   "question": "How does ISRG's valuation compare to its sector averages?",
   "answer": "Intuitive Surgical Inc. (ISRG) has a P/E ratio of 40.03, which is in line with the sector average of 40.03. Its revenue growth of 18.5% is strong compared to the sector average of 10.00%."
  },
  {
   "question": "What is the Wall Street consensus for ISRG stock?",
   "answer": "The Wall Street consensus for ISRG is predominantly Buy, with 33 analysts covering the stock. The consensus score is 73 out of 100, with 7 Strong Buys, 17 Buys, and 8 Holds."
  },
  {
   "question": "Has Intuitive Surgical Inc. (ISRG) met its recent earnings expectations?",
   "answer": "Yes, Intuitive Surgical Inc. (ISRG) has consistently beaten analyst EPS estimates in recent quarters, including a 12% surprise in its latest report. However, the stock price declined following the most recent earnings release."
  },
  {
   "question": "What is the dividend yield for ISRG stock?",
   "answer": "Intuitive Surgical Inc. (ISRG) does not currently pay a dividend, with a dividend rate and yield of 0%."
  }
 ],
 "related": {
  "peopleAlsoWatch": [
   {
    "ticker": "BMY",
    "name": "Bristol-Myers Squibb Company NYSE",
    "price": "$63.37",
    "change": "-0.5961%",
    "url": "https://clearank.com/stock/bristol-myers-squibb-bmy/"
   },
   {
    "ticker": "A",
    "name": "Agilent Technologies, Inc. NYSE",
    "price": "$146.93",
    "change": "+2.66%",
    "url": "https://clearank.com/stock/agilent-technologies-a/"
   },
   {
    "ticker": "OSCR",
    "name": "Oscar Health, Inc. NYSE",
    "price": "$31.84",
    "change": "+0.2361%",
    "url": "https://clearank.com/stock/oscr-stock-analysis/"
   },
   {
    "ticker": "DXCM",
    "name": "DexCom Inc. NASDAQ",
    "price": "$84.51",
    "change": "+0.7511%",
    "url": "https://clearank.com/stock/dxcm-stock-analysis/"
   },
   {
    "ticker": "TEM",
    "name": "Tempus AI Inc NASDAQ",
    "price": "$58.74",
    "change": "-4.14%",
    "url": "https://clearank.com/stock/tempus-ai-tem/"
   },
   {
    "ticker": "CRNX",
    "name": "Crinetics Pharmaceuticals, Inc. NASDAQ",
    "price": "$84.95",
    "change": "+0.00%",
    "url": "https://clearank.com/stock/crinetics-pharmaceuticals-crnx/"
   },
   {
    "ticker": "ABBV",
    "name": "AbbVie Inc. NYSE",
    "price": "$255.00",
    "change": "+1.63%",
    "url": "https://clearank.com/stock/abbvie-abbv/"
   },
   {
    "ticker": "MRNA",
    "name": "Moderna Inc. NASDAQ",
    "price": "$148.15",
    "change": "+8.44%",
    "url": "https://clearank.com/stock/moderna-mrna/"
   }
  ],
  "comparisons": [
   {
    "ticker": "UEC vs CCJ Comparison",
    "name": "",
    "url": "https://clearank.com/compare/uec-vs-ccj/"
   },
   {
    "ticker": "CMG vs CAVA Comparison",
    "name": "",
    "url": "https://clearank.com/compare/cmg-vs-cava/"
   },
   {
    "ticker": "SCHD vs VIG Comparison",
    "name": "",
    "url": "https://clearank.com/compare/schd-vs-vig/"
   }
  ],
  "sectorHub": {
   "text": "Browse all Healthcare →",
   "url": "https://clearank.com/sector/healthcare/"
  },
  "Newly Tracked": [
   {
    "ticker": "ILMN",
    "text": "Illumina Inc.",
    "url": "https://clearank.com/stock/ilmn-stock-analysis/"
   },
   {
    "ticker": "KEYS",
    "text": "Keysight Technologies, Inc.",
    "url": "https://clearank.com/stock/keys-stock-analysis/"
   },
   {
    "ticker": "BRO",
    "text": "Brown & Brown Inc.",
    "url": "https://clearank.com/stock/bro-stock-analysis/"
   },
   {
    "ticker": "SYY",
    "text": "Sysco Corp.",
    "url": "https://clearank.com/stock/syy-stock-analysis/"
   },
   {
    "ticker": "FIS",
    "text": "Fidelity National Information Services, Inc.",
    "url": "https://clearank.com/stock/fis-stock-analysis/"
   }
  ],
  "Top Movers (24h)": [
   {
    "ticker": "THETA/USD",
    "text": "↑ 15.25%",
    "url": "https://clearank.com/crypto/theta-network-theta-usd/"
   },
   {
    "ticker": "XHLD",
    "text": "↑ 15.04%",
    "url": "https://clearank.com/stock/xhld-stock-analysis/"
   },
   {
    "ticker": "HPE",
    "text": "↑ 10.41%",
    "url": "https://clearank.com/stock/hewlett-packard-enterprise-hpe/"
   },
   {
    "ticker": "DELL",
    "text": "↑ 10.23%",
    "url": "https://clearank.com/stock/dell-technologies-dell/"
   },
   {
    "ticker": "IMSR",
    "text": "↓ 9.79%",
    "url": "https://clearank.com/stock/terrestrial-energy-imsr/"
   }
  ],
  "Also in Healthcare": [
   {
    "ticker": "BDX",
    "text": "Becton, Dickinson and Company",
    "url": "https://clearank.com/stock/bdx-stock-analysis/"
   },
   {
    "ticker": "IQV",
    "text": "IQVIA Holdings Inc.",
    "url": "https://clearank.com/stock/iqvia-iqv/"
   },
   {
    "ticker": "JNJ",
    "text": "Johnson & Johnson",
    "url": "https://clearank.com/stock/johnson-johnson-jnj/"
   },
   {
    "ticker": "RMD",
    "text": "ResMed",
    "url": "https://clearank.com/stock/rmd-stock-analysis/"
   },
   {
    "ticker": "WST",
    "text": "West",
    "url": "https://clearank.com/stock/wst-stock-analysis/"
   }
  ]
 },
 "schema": [
  {
   "@context": "https://schema.org",
   "@graph": [
    {
     "@type": "Place",
     "@id": "https://clearank.com/#place",
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     }
    },
    {
     "@type": "Organization",
     "@id": "https://clearank.com/#organization",
     "name": "CleaRank",
     "url": "https://clearank.com",
     "sameAs": [
      "https://twitter.com/CleaRank",
      "https://www.linkedin.com/company/clearank/",
      "https://www.youtube.com/@CleaRank"
     ],
     "email": "info@clearank.com",
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     },
     "logo": {
      "@type": "ImageObject",
      "@id": "https://clearank.com/#logo",
      "url": "https://clearank.com/wp-content/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "contentUrl": "https://clearank.com/wp-content/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "caption": "CleaRank",
      "inLanguage": "en-US",
      "width": "336",
      "height": "153"
     },
     "description": "The CleaRank vision is to bring clarity to the online trading industry and protect trader interests. We use our proprietary technology, expert analysis and verified trader insights, to deliver data driven broker evaluations you can trust. Our CLEAR™ Score is our foundation, a transparent, unbiased methodology that assesses brokers and firms based on the most critical factors including regulation, fees, platform reliability, and real user experiences. We are here to change an unfair system and unlike other review sites that are influenced by partnerships or subjective opinions, CleaRank is 100% independent–abiding by our rigorous CLEAR™ editorial code. We do not accept financial incentives from brokers, so what you see is what you get with no hidden agendas, just honest, actionable feedback. Clear data. Honest reviews. That's the CleaRank promise",
     "numberOfEmployees": {
      "@type": "QuantitativeValue",
      "value": "40"
     },
     "location": {
      "@id": "https://clearank.com/#place"
     }
    },
    {
     "@type": "WebSite",
     "@id": "https://clearank.com/#website",
     "url": "https://clearank.com",
     "name": "CleaRank",
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "inLanguage": "en-US"
    },
    {
     "@type": "ImageObject",
     "@id": "https://clearank.com/wp-content/uploads/2026/06/intuitive-surgical-isrg.png",
     "url": "https://clearank.com/wp-content/uploads/2026/06/intuitive-surgical-isrg.png",
     "width": "1280",
     "height": "720",
     "caption": "Intuitive Surgical (ISRG) stock price analysis chart for June 2026",
     "inLanguage": "en-US"
    },
    {
     "@type": "BreadcrumbList",
     "@id": "https://clearank.com/stock/intuitive-surgical-isrg/#breadcrumb",
     "itemListElement": [
      {
       "@type": "ListItem",
       "position": "1",
       "item": {
        "@id": "https://clearank.com",
        "name": "Home"
       }
      },
      {
       "@type": "ListItem",
       "position": "2",
       "item": {
        "@id": "https://clearank.com/stock/intuitive-surgical-isrg/",
        "name": "Intuitive Surgical (ISRG) Stock Price Analysis"
       }
      }
     ]
    },
    {
     "@type": "WebPage",
     "@id": "https://clearank.com/stock/intuitive-surgical-isrg/#webpage",
     "url": "https://clearank.com/stock/intuitive-surgical-isrg/",
     "name": "Intuitive Surgical (ISRG) Stock Forecast (2026)",
     "datePublished": "2026-06-26T09:31:16+00:00",
     "dateModified": "2026-09-10T12:21:59+00:00",
     "isPartOf": {
      "@id": "https://clearank.com/#website"
     },
     "primaryImageOfPage": {
      "@id": "https://clearank.com/wp-content/uploads/2026/06/intuitive-surgical-isrg.png"
     },
     "inLanguage": "en-US",
     "breadcrumb": {
      "@id": "https://clearank.com/stock/intuitive-surgical-isrg/#breadcrumb"
     }
    },
    {
     "@type": "Organization",
     "@id": "https://clearank.com/writer/clearank/",
     "name": "CleaRank",
     "description": "CleaRank's vision is to bring clarity to the online trading industry and protecting trader interests by delivering data-driven broker evaluations you can trust.",
     "url": "https://clearank.com/writer/clearank/",
     "image": {
      "@type": "ImageObject",
      "@id": "https://secure.gravatar.com/avatar/4900cf75f960a22a21f1c864e98abc4d5285fa159ea1025d0e8a9db5136e28ef?s=96&d=mm&r=g",
      "url": "https://secure.gravatar.com/avatar/4900cf75f960a22a21f1c864e98abc4d5285fa159ea1025d0e8a9db5136e28ef?s=96&d=mm&r=g",
      "caption": "CleaRank",
      "inLanguage": "en-US"
     },
     "sameAs": [
      "https://clearank.com/",
      "https://twitter.com/CleaRank",
      "https://www.linkedin.com/company/clearank/",
      "https://www.youtube.com/@CleaRank"
     ],
     "worksFor": {
      "@id": "https://clearank.com/#organization"
     },
     "logo": "https://clearank.com/wp-content/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg"
    },
    {
     "@type": "Article",
     "headline": "Intuitive Surgical (ISRG) Stock Forecast (2026)",
     "datePublished": "2026-06-26T09:31:16+00:00",
     "dateModified": "2026-09-10T12:21:59+00:00",
     "author": {
      "@id": "https://clearank.com/writer/clearank/",
      "name": "CleaRank"
     },
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "description": "Intuitive Surgical Inc. (ISRG) stock: Healthcare, Medical Instruments & Supplies. $126.6B market cap. AI rating, technicals, 2030 forecast and trade plans.",
     "name": "Intuitive Surgical (ISRG) Stock Forecast (2026)",
     "@id": "https://clearank.com/stock/intuitive-surgical-isrg/#richSnippet",
     "isPartOf": {
      "@id": "https://clearank.com/stock/intuitive-surgical-isrg/#webpage"
     },
     "image": {
      "@id": "https://clearank.com/wp-content/uploads/2026/06/intuitive-surgical-isrg.png"
     },
     "inLanguage": "en-US",
     "mainEntityOfPage": {
      "@id": "https://clearank.com/stock/intuitive-surgical-isrg/#webpage"
     }
    }
   ]
  },
  {
   "@context": "https://schema.org",
   "@type": "FinancialProduct",
   "name": "Intuitive Surgical Inc. (ISRG)",
   "tickerSymbol": "ISRG",
   "url": "https://clearank.com/stock/intuitive-surgical-isrg/",
   "description": "AI-powered financial analysis for Intuitive Surgical Inc. (ISRG) including technical indicators, market metrics, valuation, and price targets - refreshed daily by CleaRank Financial AI.",
   "exchange": "NASDAQ",
   "offers": {
    "@type": "Offer",
    "price": 358.08,
    "priceCurrency": "USD",
    "availability": "https://schema.org/InStock",
    "url": "https://clearank.com/stock/intuitive-surgical-isrg/",
    "priceValidUntil": "2026-09-12"
   }
  },
  {
   "@context": "https://schema.org",
   "@type": "FAQPage",
   "mainEntity": [
    {
     "@type": "Question",
     "name": "Is Intuitive Surgical Inc. (ISRG) stock a buy right now?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Intuitive Surgical Inc. (ISRG) is currently rated as a Buy by Wall Street analysts, with a median price target of $484.00, suggesting a 37% upside from its current price of $353.24. The stock's RSI is oversold, which could indicate a potential near-term bounce, but significant insider selling presents a notable risk."
     }
    },
    {
     "@type": "Question",
     "name": "What is ISRG's stock price forecast for 2030?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Based on Monte Carlo simulations, Intuitive Surgical Inc. (ISRG) has a projected base case price of $547.35 by 2030, with a downside projection of $234.06 and an upside projection of $1280.01. These are statistical outcomes, not guarantees."
     }
    },
    {
     "@type": "Question",
     "name": "What are the biggest risks facing Intuitive Surgical Inc. (ISRG)?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "The primary risks for ISRG include significant insider selling totaling $139.3 million, a bearish technical trend with the stock trading below key moving averages, and potential competitive pressures in the robotic surgery market."
     }
    },
    {
     "@type": "Question",
     "name": "How does ISRG's valuation compare to its sector averages?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Intuitive Surgical Inc. (ISRG) has a P/E ratio of 40.03, which is in line with the sector average of 40.03. Its revenue growth of 18.5% is strong compared to the sector average of 10.00%."
     }
    },
    {
     "@type": "Question",
     "name": "What is the Wall Street consensus for ISRG stock?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "The Wall Street consensus for ISRG is predominantly Buy, with 33 analysts covering the stock. The consensus score is 73 out of 100, with 7 Strong Buys, 17 Buys, and 8 Holds."
     }
    },
    {
     "@type": "Question",
     "name": "Has Intuitive Surgical Inc. (ISRG) met its recent earnings expectations?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Yes, Intuitive Surgical Inc. (ISRG) has consistently beaten analyst EPS estimates in recent quarters, including a 12% surprise in its latest report. However, the stock price declined following the most recent earnings release."
     }
    },
    {
     "@type": "Question",
     "name": "What is the dividend yield for ISRG stock?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Intuitive Surgical Inc. (ISRG) does not currently pay a dividend, with a dividend rate and yield of 0%."
     }
    }
   ]
  }
 ]
}